Innovations In Orally Disintegrating Tablets For Pediatric Drug Delivery

Global regulatory requirements for pediatric drug trials have resulted in a substantial increase in industry-led research involving children. A significant hurdle in this area is the development of appropriate drug delivery systems, complicated by the wide physiological and developmental variations across pediatric age groups. Orally disintegrating tablets (ODTs) offer a potential solution for improving medication adherence in children. Their rapid dissolution in the mouth eliminates the need for water and minimizes choking hazards, making them a more palatable option for younger patients.

This webinar will explore the evolving field of pediatric drug formulations, with a focus on the increasing role of ODTs as a specialized and practical delivery method for children. It will address the inherent challenges of developing medications for pediatric use, examine innovative strategies being employed, and discuss the crucial considerations that guide the design of these child-centered treatments.